Home › Quitting Smoking › NCT06213532
CONNECTing to LungCare
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * English, Spanish and Cantonese speaking * Age \>= 18 years old * Primary care patients at the University of California, San Francisco (UCSF) General Internal Medicine (GIM) clinics * Must be current smokers and/or candidates for Lung Cancer Screening (LCS). Key Informant Interviews: \- Must be working in one of the clinics participating in CONNECTing to LungCare. Exclusion Criteria: * Not a current smoker
About the study
This study evaluates a smoking cessation intervention (CONNECTing to LungCare) for improving shared decision-making conversations about smoking cessation and lung cancer screening between patients and providers. Shared decision making is a patient care model in which providers offer information regarding risks and benefits, patients express their values and preferences, and then healthcare decisions are jointly discussed between the patient and provider. Patient education, aided by decision support tools, can increase patients' knowledge, decrease their decisional conflict, promote decision making, and improve the patients' perception of risk. CONNECTing to LungCare is an interactive education intervention that addresses lung cancer screening and smoking cessation and provides participants with a tailored summary that may make them more likely to have shared decision-making discussions with their providers about smoking cessation and lung cancer screening.
What is being tested
- Smoking Cessation Intervention (behavioral)
- Saliva Collection (other)
- Survey Administration (other)
Sponsor: University of California, San Francisco · Participants: 152 · Started: Dec 3, 2024
Contact the study team
- Judith Walsh · Phone: (415) 502-0862
Official record on ClinicalTrials.gov — NCT06213532
Locations in the U.S.
| California | University of California, San Francisco, San Francisco |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.